Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
BMJ Open
|
December 30, 2025
Rationale and design of the AlloFIST trial: a phase I/IIa study to evaluate dose escalation of allogeneic adipose-derived stroma/stem cells for the treatment of Crohn's fistula
Etienne Buscail, Cyrielle Gilletta de Saint Joseph, Marine Lebrin, et al.
Gut Microbes
|
June 18, 2026
High thrombin activity associated with crohn's disease induces microbiota pathogenicity contributing to mucosal inflammation
Guillaume Le Cosquer, Melissa Pannier, Julie Thevenin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 15, 2015
First-in-man phase 1 clinical trial of gene therapy for advanced pancreatic cancer: safety, biodistribution, and preliminary clinical findings
Louis Buscail, Barbara Bournet, Fabienne Vernejoul, et al.
Ebiomedicine
|
July 7, 2020
Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer
Rémy Nicolle, Yuna Blum, Pauline Duconseil, et al.
Journal of Crohn'S & Colitis
|
November 17, 2020
Increased Mucosal Thrombin is Associated with Crohn's Disease and Causes Inflammatory Damage through Protease-activated Receptors Activation
Jean-Paul Motta, Simone Palese, Carmine Giorgio, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 8, 2017
Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases
Diane Lorenzo, Frédérique Maire, Carmen Stefanescu, et al.
EMBO Molecular Medicine
|
May 25, 2021
Pancreatic cancer intrinsic PI3Kα activity accelerates metastasis and rewires macrophage component
Benoit Thibault, Fernanda Ramos-Delgado, Elvire Pons-Tostivint, et al.
International Journal of Epidemiology
|
May 20, 2026
Development and validation of an epidemiological risk score for early detection of pancreatic cancer in high-risk individuals within the IMAGene project
Lois Riobó-Mayo, Lluis Salvador, Alex Teulé, et al.
Journal of Gastrointestinal Oncology
|
May 18, 2023
Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma
David Piquemal, Roman Bruno, Barbara Bournet, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
December 14, 2022
The PRSS3P2 and TRY7 deletion copy number variant modifies risk for chronic pancreatitis
Emmanuelle Masson, Maren Ewers, Sumit Paliwal, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
BMJ Open
|
December 30, 2025
Rationale and design of the AlloFIST trial: a phase I/IIa study to evaluate dose escalation of allogeneic adipose-derived stroma/stem cells for the treatment of Crohn's fistula
Etienne Buscail, Cyrielle Gilletta de Saint Joseph, Marine Lebrin, et al.
Gut Microbes
|
June 18, 2026
High thrombin activity associated with crohn's disease induces microbiota pathogenicity contributing to mucosal inflammation
Guillaume Le Cosquer, Melissa Pannier, Julie Thevenin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 15, 2015
First-in-man phase 1 clinical trial of gene therapy for advanced pancreatic cancer: safety, biodistribution, and preliminary clinical findings
Louis Buscail, Barbara Bournet, Fabienne Vernejoul, et al.
Ebiomedicine
|
July 7, 2020
Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer
Rémy Nicolle, Yuna Blum, Pauline Duconseil, et al.
Journal of Crohn'S & Colitis
|
November 17, 2020
Increased Mucosal Thrombin is Associated with Crohn's Disease and Causes Inflammatory Damage through Protease-activated Receptors Activation
Jean-Paul Motta, Simone Palese, Carmine Giorgio, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 8, 2017
Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases
Diane Lorenzo, Frédérique Maire, Carmen Stefanescu, et al.
EMBO Molecular Medicine
|
May 25, 2021
Pancreatic cancer intrinsic PI3Kα activity accelerates metastasis and rewires macrophage component
Benoit Thibault, Fernanda Ramos-Delgado, Elvire Pons-Tostivint, et al.
International Journal of Epidemiology
|
May 20, 2026
Development and validation of an epidemiological risk score for early detection of pancreatic cancer in high-risk individuals within the IMAGene project
Lois Riobó-Mayo, Lluis Salvador, Alex Teulé, et al.
Journal of Gastrointestinal Oncology
|
May 18, 2023
Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma
David Piquemal, Roman Bruno, Barbara Bournet, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
December 14, 2022
The PRSS3P2 and TRY7 deletion copy number variant modifies risk for chronic pancreatitis
Emmanuelle Masson, Maren Ewers, Sumit Paliwal, et al.
Page
of 7